1 |
Kuo CF, Grainge MJ, Zhang W, et al. Global epidemiology of gout: prevalence, incidence and risk factors [J]. Nat Rev Rheumatol, 2015, 11(11): 649-662.
|
2 |
Akiyama K, Maeda S, Matsuyama T, et al. Vector flow mapping analysis of left ventricular energetic performance in healthy adult volunteers [J]. BMC Cardiovasc Disord, 2017, 17(1): 21.
|
3 |
Martinez-Legazpi P, Bermejo J, Benito Y, et al. Contribution of the diastolic vortex ring to left ventricular filling [J]. J Am Coll Cardiol, 2014, 64(16): 1711-1721.
|
4 |
Disveld IJM, Zoakman S, Jansen TLTA , et al. Crystal-proven gout patients have an increased mortality due to cardiovascular diseases, cancer, and infectious diseases especially when having tophi and/or high serum uric acid levels: a prospective cohort study [J]. Clin Rheumatol, 2019, 38(5): 1385-1391.
|
5 |
Szczurek W, Szyguła-Jurkiewicz B. Oxidative stress and inflammatory markers-the future of heart failure diagnostics? [J]. Kardiochir Torakochirurgia Pol, 2015, 12(2): 145-149.
|
6 |
中华医学会风湿病学分会. 原发性痛风诊断和治疗指南 [J]. 中华风湿病学杂志, 2011, 15(6): 410-413.
|
7 |
Neogi T, Jansen TL, Dalbeth N, et al. 2015 Gout classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative [J]. Ann Rheum Dis, 2015, 74(10): 1789-1798.
|
8 |
Gamala M, Jacobs JWG, Van Laar JM. The diagnostic performance of dual energy CT for diagnosing gout: a systematic literature review and meta-analysis [J]. Rheumatology (Oxford), 2019, 58(12): 2117-2121.
|
9 |
Chen X, Wang Y, Wang W, et al. Assessment of left ventricular energy loss using vector flow mapping in patients with stages 1-3 chronic kidney disease [J]. BMC Cardiovasc Disord, 2020, 20(1): 355.
|
10 |
Kapetanovic R, Bokil NJ, Sweet MJ. Innate immune perturbations, accumulating DAMPs and inflammasome dysregulation: A ticking time bomb in ageing [J]. Ageing Res Rev, 2015, 24(Pt A): 40-53.
|
11 |
Fujimura Y, Yamauchi Y, Murase T, et al. Relationship between plasma xanthine oxidoreductase activity and left ventricular ejection fraction and hypertrophy among cardiac patients [J]. PLoS One, 2017, 12(8): e0182699.
|
12 |
Giannopoulos G, Angelidis C, Deftereos S. Gout and arrhythmias: In search for causation beyond association [J]. Trends Cardiovasc Med, 2019, 29(1): 41-47.
|
13 |
Hong GR, Pedrizzetti G, Tonti G, et al. Characterization and quantification of vortex flow in the human left ventricle by contrast echocardiography using vector particle image velocimetry [J]. JACC Cardiovasc Imaging, 2008, 1(6): 705-717.
|
14 |
Lin M, Hao L, Cao Y, et al. Successful radiofrequency catheter ablation of atrial fibrillation is associated with improvement in left ventricular energy loss and mechanics abnormalities [J]. Int J Cardiovasc Imaging, 2019, 35(3): 427-435.
|
15 |
Lee J H, Yang JA, Shin K, et al. Elderly patients exhibit stronger inflammatory responses during gout attacks [J]. J Korean Med Sci, 2017, 32(12): 1967-1973.
|
16 |
Lin JC, Lin CL, Chen MC, et al. Gout, not hyperuricemia alone, impairs left ventricular diastolic function [J]. Arthritis Res Ther, 2015, 17: 323.
|
17 |
Gancheva RN, Kundurdjiev AI, Ivanova MG, et al. Ultrasonographic measurement of carotid artery resistive index and diastolic function of the heart in gout patients [J]. Rheumatol Int, 2015, 35(8): 1369-1375.
|
18 |
Pan KL, Lin JC, Lin CL, et al. Impact of gout on left atrial function: a prospective speckle-tracking echocardiographic study [J]. PLoS One, 2014, 9(9): e108357.
|
19 |
Zhang X, Lu Q, Zhang Z, et al. Value of three-dimensional speckle tracking echocardiography to assess left ventricular function in hyperuricemia patients [J]. Clin Rheumatol, 2018, 37(9): 2539-2545.
|
20 |
Nagueh SF, Smiseth OA, Appleton CP, et al. Recommendations for the evaluation of left ventricular diastolic function by echocardiography: An update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging [J]. J Am Soc Echocardiogr, 2016, 29(4): 277-314.
|
21 |
中华医学会超声医学分会超声心动图学组, 中国医师协会心血管分会超声心动图专业委员会. 超声心动图评估心脏收缩和舒张功能临床应用指南 [J]. 中华超声影像学杂志, 2020, 29(6): 461-477.
|